Avelos Therapeutics
Developer of biomarker-driven anti-cancer targeted therapies intended for cancer treatment. The company is developing targeted, biomarker-driven once-therapeutics focused on the areas of cell cycle re...
Valuation
$0
Share Price
N/A
Total Raised
$21.7M
Last Round
N/A